Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Asymptomatic infection and disappearance of clinical symptoms of COVID-19 infectors in China 2022-2023: a cross-sectional study.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • المصدر:
      Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE
    • بيانات النشر:
      Original Publication: London : Nature Publishing Group, copyright 2011-
    • الموضوع:
    • نبذة مختصرة :
      To explore the clinical characteristics of patients infected with SARS-CoV-2 nationwide, especially the effect factors of asymptomatic infection and disappearance of clinical symptoms. A total of 66,448 COVID-19 patients in China who have been diagnosed by nucleic acid test or rapid antigen test were surveyed online (December 24, 2022 to January 16, 2023). Our cross-sectional study used descriptive analyses and binary Logistics regression model to assess the correlation between the clinical characteristics and relative factors, including age, gender, pre-existing conditions, reinfection, vaccination and treatment. A total of 64,515 valid questionnaires were collected. Among included participants, 5969 of which were asymptomatic. The symptoms were mainly upper respiratory symptoms, including dry and itchy throat (64.16%), sore throat (59.95%), hoarseness (57.90%), nasal congestion (53.39%). In binary Logistics regression model, we found that male, no pre-existing conditions, reinfection and vaccination have positive correlations with the appearance of asymptomatic COVID-19 patients. In Cox proportional-hazards regression model, considering all clinical symptoms disappeared in 14 days as outcome, we found that ≤ 60 years old, male, no pre-existing conditions, vaccination and adopted treatment have positive correlations with rapid amelioration of clinical symptoms in COVID-19 patients. The clinical symptoms of the participants were mainly upper respiratory symptoms which were according with the infection of Omicron variant. Factors including age, gender, pre-existing conditions and reinfection could influence the clinical characteristics and prognosis of COVID-19 patients. Importantly, vaccination has positive significance for the prevention and treatment of COVID-19. Lastly, the use of Chinese medicine maybe beneficial to COVID-19 patients, however, reasonable guidance is necessary.
      (© 2024. The Author(s).)
    • References:
      J Indian Med Assoc. 2009 Jun;107(6):403-5. (PMID: 19886379)
      PLoS One. 2020 Nov 9;15(11):e0240784. (PMID: 33166287)
      BMJ. 2023 Jan 11;380:e072529. (PMID: 36631153)
      Proc Natl Acad Sci U S A. 2021 Aug 24;118(34):. (PMID: 34376550)
      Science. 2022 May 6;376(6593):eabn4947. (PMID: 35289632)
      Brain Behav Immun. 2022 Mar;101:93-135. (PMID: 34973396)
      Ann Intern Med. 2022 Nov;175(11):1560-1571. (PMID: 36252247)
      Lancet Diabetes Endocrinol. 2022 Mar;10(3):221-230. (PMID: 35114136)
      Nat Med. 2022 Aug;28(8):1706-1714. (PMID: 35879616)
      Nat Med. 2022 Mar;28(3):583-590. (PMID: 35132265)
      Lancet Neurol. 2020 Sep;19(9):767-783. (PMID: 32622375)
      Lancet Infect Dis. 2022 Jun;22(6):781-790. (PMID: 35366962)
      MMWR Morb Mortal Wkly Rep. 2020 Jul 31;69(30):993-998. (PMID: 32730238)
      Pharmacol Res. 2020 Aug;158:104896. (PMID: 32438037)
      BMJ. 2023 Feb 8;380:e074035. (PMID: 36754426)
      Nature. 2021 Dec;600(7888):197-199. (PMID: 34857948)
      Lancet. 2021 Jan 16;397(10270):220-232. (PMID: 33428867)
      N Engl J Med. 2022 Apr 21;386(16):1532-1546. (PMID: 35249272)
      N Engl J Med. 2020 Jun 18;382(25):e102. (PMID: 32356626)
      N Engl J Med. 2022 Mar 31;386(13):1207-1220. (PMID: 35172051)
      Lancet. 2021 May 1;397(10285):1646-1657. (PMID: 33901420)
      BMJ. 2022 Oct 13;379:e071050. (PMID: 36229057)
      JAMA Netw Open. 2022 Sep 1;5(9):e2232760. (PMID: 36136332)
      Lancet Diabetes Endocrinol. 2020 Oct;8(10):813-822. (PMID: 32798472)
      Lancet. 2021 May 15;397(10287):1819-1829. (PMID: 33964222)
      Sci Rep. 2021 Aug 9;11(1):16144. (PMID: 34373540)
    • Contributed Indexing:
      Keywords: COVID-19; Clinical characteristics; Cross-sectional study; Regression model; Related factors
    • الموضوع:
      Date Created: 20240806 Date Completed: 20240806 Latest Revision: 20240812
    • الموضوع:
      20240813
    • الرقم المعرف:
      PMC11303783
    • الرقم المعرف:
      10.1038/s41598-024-68162-8
    • الرقم المعرف:
      39107338